Manufacturing

With a new North American headquarters and expanded operations, Almac is furthering its transatlantic approach to contract development and manufacturing.

A recent industry survey shows keen interest in improving bioreactors and cell-culture media.

The increase in aseptic processing driven by the growing number of biologically-derived products has led to an increase in freeze-drying applications in this area at both research and production scales.

A PQRI expert working group provides case study examples of risk-management applications.

The performance of biotechnology venture capital and investment is lackluster at best.

Getting an answer is easy-asking the right question is apparently more difficult.

Editor's picks of new manufacturing products for July 2011.

A new report places pharmaceutical and healthcare companies ahead in corporate and social governance.

The solid form of an API plays a crucial role in drug quality, and advancing methods for screening, detection, and characterization is key.

Member states in the EU are working to implement the newly passed Falsified Medicines Directive.

Follow-on versions of complex biologics require extensive expertise in development and regulatory procedures.

High demand could lead to innovation in controlled-release injectables.

US support of regenerative medicine is essential for maintaining a lead on healthcare innovation.

A PQRI expert working group provides case study examples of risk-management applications.

Better strategies and practices in sourcing and procurement can contribute to the bottom line.

Pharmaceutical manufacturers look to various solutions to resolve the challenge of poorly soluble drugs

Pharma's drive for manufacturing efficiency is bolstering particle-characterization technologies.

The authors investigate the influence of hydro-alcoholic media on hydration and drug release from polyethylene oxide extended-release matrices.

Which route will we take to arrive at a national stem-cell policy?

The current review describes the role and selection of excipients, pellet core, coating materials, and compression with various cushioning agents.

Switzerland is an important power in Europe's pharmaceutical industry.

Product degradation is often overlooked compared with other supply chain issues, but if left unchecked can lead to the market entry of substandard medicines, whether through ignorance or gross negligence.

Lyophilisation or freeze-drying is widely used in the pharmaceutical industry for a variety of reasons.

Single-use filtration and fill–finish technologies can be used as part of a lean manufacturing strategy to boost production, and reduce manufacturing waste and costs.

President Obama unveiled an Advanced Manufacturing Partnership designed to reinvigorate the country's manufacturing sector.